Lognos B, Glondu-Lassis M, Senesse P, Gutowski M, Jacot W, Lemanski C, Amouyal M, Azria D, Guerdoux E, Bourgier C [Non-pharmalogical interventions and breast cancer: What benefit in addition to radiotherapy?]. Cancer Radiother. 2022;26(4):637-645. doi:10.1016/j.canrad.2021.09.011
Thomas Q, Quesada S, D'Hondt V, Belaroussi I, Laas E, Classe J-M, Fabbro M, Colombo P-E [Combining surgery and medical treatments for ovarian cancer: Is there an optimal strategy?]. Bull Cancer. 2022;109(2):197-215. doi:10.1016/j.bulcan.2021.11.013
Modi S, Jacot W, Yamashita T, Sohn J, Vidal M, Tokunaga E, Tsurutani J, Ueno N, Prat A, Chae Y, Lee K, Niikura N, Park Y, Xu B, Wang X, Gil-Gil M, Li W, Pierga J-Y, Im S-A, Moore H, Rugo H, Yerushalmi R, Zagouri F, Gombos A, Kim S-B, Liu Q, Luo T, Saura C, Schmid P, Sun T, Gambhire D, Yung L, Wang Y, Singh J, Vitazka P, Meinhardt G, Harbeck N, Cameron D Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer. N Engl J Med. 2022;387(1):9-20. doi:10.1056/NEJMoa2203690
Romeo C, Le Saux O, Jacobs M, Joly F, Favier L, Fumet J-D, Isambert N, Colombo P-E, Sabatier R, Bastide L, Charreton A, Devouassoux-Shisheboran M, Gertych W, Dubot C, Bello Roufai D, Bataillon G, Berton D, Kalbacher E, Pautier P, Pomel C, Cornou C, Treilleux I, Lardy-Cleaud A, Ray-Coquard I Therapeutic Challenges in Patients with Gynecologic Carcinosarcomas: Analysis of a Multicenter National Cohort Study from the French Prospective TMRG Network. Cancers (Basel). 2022;14(2):354. doi:10.3390/cancers14020354
Rouanet P, Selvy M, Jarlier M, Bugnon C, Carrier G, Mourregot A, Colombo P-E, Taoum C Tailored Management with Highly-Selective Diversion for Low Colorectal Anastomosis: Biochemical Postoperative Follow-Up and Long-Term Results from a Single-Institution Cohort. Ann Surg Oncol. 2022;29(4):2514-2524. doi:10.1245/s10434-021-11197-2
Michalet M, Bordeau K, Cantaloube M, Valdenaire S, Debuire P, Simeon S, Portales F, Draghici R, Ychou M, Assenat E, Dupuy M, Gourgou S, Colombo P-E, Fenoglietto P, Azria D, Riou O Stereotactic MR-Guided Radiotherapy for Pancreatic Tumors: Dosimetric Benefit of Adaptation and First Clinical Results in a Prospective Registry Study. Front Oncol. 2022;12. doi:10.3389/fonc.2022.842402
Bobrie A, Jarlier M, Moussion A, Jacot W Sexual quality of life assessment in young women with breast cancer during adjuvant endocrine therapy and patient-reported supportive measures. Support Care Cancer. 2022;30(4):3633-3641. doi:10.1007/s00520-022-06810-3
Bourla C, Carrier G, Taoum C, Rouanet P, Colombo P Robotic-assisted colon resection for splenic flexure cancer. J Visc Surg. 2022;159(3):234-239. doi:10.1016/j.jviscsurg.2021.08.003
Guénolé A, Velilla F, Chartier A, Rich A, Carvunis A-R, Sardet C, Simonelig M, Sobhian B RNF219 regulates CCR4-NOT function in mRNA translation and deadenylation. Sci Rep. 2022;12(1):9288. doi:10.1038/s41598-022-13309-8
Mangiardi-Veltin M, Sebbag C, Rousset-Jablonski C, Ray-Coquard I, Berkach C, Laot L, Wang Y, Abdennebi I, Labrosse J, Sautter C, Toussaint A, Sablone L, Laas E, Khallouch S, Coussy F, Santulli P, Chapron C, Bobrie A, Jacot W, Sella N, Dumas E, Sénéchal-Davin C, Espie M, Giacchetti S, Maitrot L, Plu-Bureau G, Coutant C, Guerin J, Asselain B, Fumoleau P, Rodrigues M, Decanter C, Mailliez A, Delrieu L, Lemoine A, Jouannaud C, Houdre D, Reyal F, Hamy A-S Pregnancy, fertility concerns and fertility preservation procedures in a national study of French breast cancer survivors. Reprod Biomed Online. 2022;44(6):1031-1044. doi:10.1016/j.rbmo.2021.12.019
Leenhardt F, Gauthier L, Alexandre M, Guiu S, Firmin N, Viala M, Lossaint G, Gautier C, Mollevi C, Gracia M, Mbatchi L, Evrard A, Jacot W Pharmacokinetic Variability Drives Palbociclib-Induced Neutropenia in Metastatic Breast Cancer Patients: Drug-Drug Interactions Are the Usual Suspects. Pharmaceutics. 2022;14(4):841. doi:10.3390/pharmaceutics14040841
Carbasse C, Leenhardt F, Jacot W, Perrier C, Viala M Oral targeted therapy dose adaptation in older patients with cancer: A real-life French cohort. Br J Clin Pharmacol. 2022;88(7):3370-3377. doi:10.1111/bcp.15285
Kong-Hap M-A, Andrade A, Del Rio M, Pasero P, Theillet C, Gongora C, Pourquier P Multiplexed-Based Assessment of DNA Damage Response to Chemotherapies Using Cell Imaging Cytometry. Int J Mol Sci. 2022;23(10):5701. doi:10.3390/ijms23105701
Quesada S, Jacot W Maintenance endocrine therapy plus bevacizumab for advanced or metastatic breast cancer. Lancet Oncol. 2022;23(5):557-558. doi:10.1016/S1470-2045(22)00205-4
Ratosa I, Dobnikar N, Bottosso M, Dieci M, Jacot W, Ribnikar D, Sinoquet L, Guarneri V, Znidaric T, Darlix A, Griguolo G Leptomeningeal metastases in patients with human epidermal growth factor receptor 2 positive breast cancer: Real-world data from a multicentric European cohort. Int J Cancer. 2022-06-06. doi:10.1002/ijc.34135
Neron M, Guille A, Colombo P-E, Leaha C, Adelaide J, Carbuccia N, Courtier F, Crapez E, Fabbro M, Gouy S, Mamessier E, Birnbaum D, Bertucci F, Chaffanet M Investigation of Molecular Features Involved in Clinical Responses and Survival in Advanced Endometrial Carcinoma Treated by Hormone Therapy. J Pers Med. 2022;12(5):655. doi:10.3390/jpm12050655
Boissière-Michot F, Mollevi C, Baecker V, Crapez E, Jacot W In situ hybridization for the assessment of urokinase plasminogen activator and plasminogen activator inhibitor type?1 in formalin?fixed paraffin?embedded breast cancer specimens. Int J Mol Med. 2022;49(6):82. doi:10.3892/ijmm.2022.5138
du Manoir S, Delpech H, Orsetti B, Jacot W, Pirot N, Noel J, Colombo P-E, Sardet C, Theillet C In high-grade ovarian carcinoma, platinum-sensitive tumor recurrence and acquired-resistance derive from quiescent residual cancer cells that overexpress CRYAB, CEACAM6, and SOX2. J Pathol. 2022;257(3):367-378. doi:10.1002/path.5896
Bringuier M, Carton M, Levy C, Patsouris A, Pasquier D, Debled M, Rigal O, Jacot W, Desmoulins I, Bachelot T, Ferrero J-M, Eymard J-C, Ung M, Mouret-Reynier M-A, Petit T, Chevrot M, Uwer L, Courtinard C, Frenel J-S, Vianzone A, Baldini C Enrollment of older metastatic breast cancer patients in first-line clinical trials: 9-year experience of the large-scale real-life multicenter French ESME cohort. Breast Cancer Res Treat. 2022;191(3):577-587. doi:10.1007/s10549-021-06467-2
Moinard-Butot F, Saint-Martin C, Pflumio C, Carton M, Jacot W, Cottu P-H, Dalenc F, Goncalves A, Debled M, Patsouris A, Mouret-Reynier M-A, Vanlemmens L, Leheurteur M, Emile G, Ferrero J-M, Desmoulins I, Uwer L, Eymard J-C, Cheaib B, Courtinard C, Bachelot T, Chevrot M, Petit T Efficacy of trastuzumab emtansine (T-DM1) and lapatinib after dual HER2 inhibition with trastuzumab and pertuzumab in patient with metastatic breast cancer: Retrospective data from a French multicenter real-life cohort. Breast. 2022;63. doi:10.1016/j.breast.2022.03.004
De Laurentiis M, Borstnar S, Campone M, Warner E, Bofill J, Jacot W, Dent S, Martin M, Ring A, Cottu P, Lu J, Ciruelos E, Azim H, Chatterjee S, Zhou K, Wu J, Menon-Singh L, Zamagni C Correction to: Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population. Breast Cancer Res Treat. 2022;191(1):223-224. doi:10.1007/s10549-021-06374-6
Leborne P, Colombo P An anatomical variation during para-aortic lymphadenectomy. J Visc Surg. 2022-06-01. doi:10.1016/j.jviscsurg.2022.05.001
Griguolo G, Tosi A, Dieci M, Fineberg S, Rossi V, Ventura A, Bottosso M, Bauchet L, Miglietta F, Jacob J, Fassan M, Jacot W, Conte P, Rosato A, Guarneri V A comprehensive profiling of the immune microenvironment of breast cancer brain metastases. Neuro Oncol. 2022-05-24. doi:10.1093/neuonc/noac136
Guelfi S, Orsetti B, Deleuze V, Rigau V, Bauchet L, Duffau H, Rothhut B, Hugnot J-P SLUG and Truncated TAL1 Reduce Glioblastoma Stem Cell Growth Downstream of Notch1 and Define Distinct Vascular Subpopulations in Glioblastoma Multiforme. Cancers (Basel). 2021;13(21):5393. doi:10.3390/cancers13215393
Darlix A, Hirtz C, Mollevi C, Ginestet N, Tiers L, Jacot W, Lehmann S Serum glial fibrillary acidic protein is a predictor of brain metastases in patients with metastatic breast cancer. Int J Cancer. 2021;149(8):1605-1618. doi:10.1002/ijc.33724
Institut de Recherche en Cancérologie de
